澳大利亚11月份发行的《AdverseDrugReactBull》杂志报道:自1993年以来,3名病人的死亡与服用葛兰素威康公司生产的治疗偏头痛药舒马普坦(sumatriptan,Imigran)有关。3名死亡者均为中年妇女,几小时前口服了舒马普坦后胸痛发作而死。其中2名妇女有心血管病史。事实上,另一名妇女 Adverse Drug ReactBull, released in November in Australia, reports that since 1993, the deaths of three patients were related to the use of GlaxoSmithKline’s sumatriptan (sumatriptan, migraine), a migraine drug. Three of the dead were middle-aged women, who died of chest pain after oral sumatriptan a few hours earlier. Two of the women had a history of cardiovascular disease. In fact, another woman